EA Treatment With Different Waveform for Subacute BP:Study Protocol for a Randomized Controlled Trial
- Conditions
- Bell Palsy
- Registration Number
- NCT06573697
- Lead Sponsor
- The Third Affiliated hospital of Zhejiang Chinese Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria:<br><br> 1. Patients meet the clinical classification criteria for BP, diagnosed by specialist.<br><br> 2. 1-3 weeks from onset.<br><br> 3. Male or female patients aged 18-65 years.<br><br> 4. Clearly aware, able to complete normal communication, signed informed consent.<br><br>Exclusion Criteria:<br><br> 1. Facial paralysis due to other causes, such as stroke, Guillain-Barre syndrome,<br> multiple sclerosis, encephalitis, facial nerve tumors, skin tumors, parotid tumors,<br> and facial nerve trauma;.<br><br> 2. Patients with Hunter's syndrome.<br><br> 3. Patients with bilateral facial nerve palsy.<br><br> 4. Patients with hemifacial spasm as the the main clinical symptoms.<br><br> 5. Patients with severe cardiovascular and cerebrovascular diseases, liver, kidney,<br> hematopoietic system diseases, malignant tumors and systemic organ failure, pregnant<br> or lactating patients.<br><br> 6. Patients with a tendency to bleed easily, who are not suitable for<br> electroacupuncture such as installing a pacemaker, or who cannot cooperate with<br> treatment for other reasons.
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change from Baseline score of the Facial Nerve Grading System 2.0(FNGS 2.0)
- Secondary Outcome Measures
Name Time Method Change from Baseline score of the Sunnybrook grading(SFGS) scale;Change from Baseline score of the Facial Disability Index(FDI);Change from Baseline value of the amplitude ratio of the compound muscle action potential (CMAP) of the affected side in the ENoG test.